PDF (3090K)
摘要
目的 评价自制活化凝血酶原复合物(activated Prothrombin Complex Concentrate,aPCC)的体外促凝有效性和体内潜在致血栓风险。方法 按 0. 5 IU/ mL 血浆剂量给药,通过体外实验,将自制 aPCC 浓缩物加入 FⅧ抑制物模拟血浆中,利用自动标准化凝血酶生成试验(Calibrated automated thrombin generation,CAT)、凝血酶原时间(pro-thrombin time,PT)、活化部分凝血活酶时间(activated partial thromboplastin time,APTT)、凝血酶时间(thrombin time, TT)及纤维蛋白原(fibrinogen,Fib)检测,以正常血浆和 FEIBA®作为对照评价自制 aPCC 浓缩物的促凝能力;通过动物实验,将自制 aPCC 浓缩物经颈静脉注射入大鼠体内,用 FeCl3 贴片诱导颈动脉血栓形成,再利用激光散斑血流成像监测观察大鼠颈动脉血栓生成情况,并采集大鼠血浆进行 CAT、PT、APTT、TT 及 Fib 检测,并将生理盐水和 FEIBA®做为对照评价自制 aPCC 浓缩物的潜在致血栓风险。结果 抑制物血浆中加入 aPCC 后,显著降低了抑制物血浆的 APTT、PT(均 P<0. 001)。 FEIBA®和自制 aPCC 的 APTT、PT 值无显著差异(P>0. 05)。 CAT 检测结果显示,抑制物血浆加入 aPCC 后,内源性凝血酶生成潜力(ETP)与凝血酶峰值(Peak)水平显著升高(P<0. 001),且高于正常血浆(P<0. 001),而自制 aPCC 和 FEIBA®的 ETP 无显著差异(P>0. 05)。 大鼠颈动脉血流成像监测结果显示,与 FEIBA®相比,自制 aPCC 形成的血栓较小、稳定性差,均发生自溶,大鼠颈动脉血流恢复情况较好。结论 自制 aPCC 与 FEIBA®一样能较好恢复抑制物血浆的凝血能力,且致血栓风险性较低。
Abstract
Objective To evaluate the in vitro procoagulant efficacy and in vivo potential thrombogenic risk of self-prepared activated prothrombin complex concentrate (aPCC). Methods The preparation was administered at a dose of 0. 5 IU per milliliter of plasma. For in vitro assays, the self-prepared aPCC concentrate was added to plasma spiked with factor Ⅷ (FⅧ) inhibitors. Calibrated automated thrombin generation (CAT), prothrombin time (PT), activated partial thrombo-plastin time (APTT), thrombin time (TT), and fibrinogen (Fib) quantification were performed. Normal saline and FEIBA® were set as controls to evaluate the procoagulant capacity of the self-prepared aPCC concentrate. For in vivo animal studies, the self-prepared aPCC concentrate was injected into rats via the jugular vein. A ferric chloride (FeCl3) filter pa-per patch was applied to induce carotid arterial thrombosis. Laser speckle blood flow imaging was used to continuously moni-tor thrombus formation in the rat carotid artery. Plasma samples were collected from rats for CAT, PT, APTT, TT and Fib testing, with normal saline and FEIBA® as controls to evaluate the potential thrombogenic risk of the self-prepared aPCC concentrate. Results Supplementation with aPCC significantly shortened APTT and PT values in inhibitor-spiked plasma (all P< 0. 001). There were no statistically significant differences in APTT and PT between FEIBA® and self-prepared aPCC (P>0. 05). CAT results demonstrated that adding aPCC to inhibitor-containing plasma markedly increased endoge-nous thrombin potential (ETP) and peak thrombin concentration (Peak) (P<0. 001), with both parameters higher than those of normal plasma (P<0. 05). No significant intergroup difference in ETP was observed between self-prepared aPCC and FEIBA® (P>0. 05). Carotid blood flow imaging in rats revealed that, compared with FEIBA®, thrombi induced by self-prepared aPCC were smaller and less stable, and all underwent spontaneous lysis, accompanied by better restoration of ca-rotid blood perfusion. Conclusion The self-prepared aPCC restores coagulation function in inhibitor-spiked plasma to a comparable extent as FEIBA®, while exhibiting a lower thrombogenic risk.
关键词
Key words
[Author(id=1329502401195549088, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=panxu@ibt.pumc.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329502401266852258, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, authorId=1329502401195549088, language=EN, stringName=Xu PAN, firstName=Xu, middleName=null, lastName=PAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1 Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu 610052, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329502401346544035, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, authorId=1329502401195549088, language=CN, stringName=潘旭, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1 中国医学科学院 北京协和医学院 输血研究所,四川 成都 610052, bio={"content":"潘旭(1987-),女,助理研究员,Email:panxu@ibt.pumc.edu.cn
"}, bioImg=null, bioContent=潘旭(1987-),女,助理研究员,Email:panxu@ibt.pumc.edu.cn
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329502400922919318, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, xref=1, ext=[AuthorCompanyExt(id=1329502400943890839, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, companyId=1329502400922919318, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1 Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu 610052, China), AuthorCompanyExt(id=1329502400960668056, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, companyId=1329502400922919318, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1 中国医学科学院 北京协和医学院 输血研究所,四川 成都 610052)])]), Author(id=1329502401401069989, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329502401472373159, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, authorId=1329502401401069989, language=EN, stringName=Yuwei HUANG, firstName=Yuwei, middleName=null, lastName=HUANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2 Jianyang People′s Hospital, Chengdu 641400, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329502401535287720, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, authorId=1329502401401069989, language=CN, stringName=黄雨薇, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2 简阳市人民医院,四川 成都 641400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329502401015194009, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, xref=2, ext=[AuthorCompanyExt(id=1329502401036165530, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, companyId=1329502401015194009, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2 Jianyang People′s Hospital, Chengdu 641400, China), AuthorCompanyExt(id=1329502401052942747, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, companyId=1329502401015194009, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2 简阳市人民医院,四川 成都 641400)])]), Author(id=1329502401585619370, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329502401652728236, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, authorId=1329502401585619370, language=EN, stringName=Liehuo MAO, firstName=Liehuo, middleName=null, lastName=MAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3 Zhejiang Int Biologics Marketing Co., Ltd, Hangzhou 310014, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329502401698865581, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, authorId=1329502401585619370, language=CN, stringName=毛烈火, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3 浙江英特生物制品营销有限公司,浙江 杭州 310014, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329502401107468700, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, xref=3, ext=[AuthorCompanyExt(id=1329502401124245917, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, companyId=1329502401107468700, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3 Zhejiang Int Biologics Marketing Co., Ltd, Hangzhou 310014, China), AuthorCompanyExt(id=1329502401141023134, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, companyId=1329502401107468700, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3 浙江英特生物制品营销有限公司,浙江 杭州 310014)])]), Author(id=1329502401749197231, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329502401816306097, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, authorId=1329502401749197231, language=EN, stringName=Pan SUN, firstName=Pan, middleName=null, lastName=SUN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1 Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu 610052, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329502401866637746, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, authorId=1329502401749197231, language=CN, stringName=孙盼, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1 中国医学科学院 北京协和医学院 输血研究所,四川 成都 610052, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329502400922919318, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, xref=1, ext=[AuthorCompanyExt(id=1329502400943890839, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, companyId=1329502400922919318, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1 Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu 610052, China), AuthorCompanyExt(id=1329502400960668056, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, companyId=1329502400922919318, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1 中国医学科学院 北京协和医学院 输血研究所,四川 成都 610052)])]), Author(id=1329502401916969396, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329502401979883958, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, authorId=1329502401916969396, language=EN, stringName=Changqing LI, firstName=Changqing, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1 Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu 610052, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329502402026021303, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, authorId=1329502401916969396, language=CN, stringName=李长清, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1 中国医学科学院 北京协和医学院 输血研究所,四川 成都 610052, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329502400922919318, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, xref=1, ext=[AuthorCompanyExt(id=1329502400943890839, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, companyId=1329502400922919318, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1 Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu 610052, China), AuthorCompanyExt(id=1329502400960668056, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, companyId=1329502400922919318, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1 中国医学科学院 北京协和医学院 输血研究所,四川 成都 610052)])]), Author(id=1329502402076352953, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, orderNo=5, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=xi.du@ibt.pumc.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329502402139267515, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, authorId=1329502402076352953, language=EN, stringName=Xi DU, firstName=Xi, middleName=null, lastName=DU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1 Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu 610052, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329502402185404860, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, authorId=1329502402076352953, language=CN, stringName=杜晞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1 中国医学科学院 北京协和医学院 输血研究所,四川 成都 610052, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329502400922919318, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, xref=1, ext=[AuthorCompanyExt(id=1329502400943890839, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, companyId=1329502400922919318, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1 Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu 610052, China), AuthorCompanyExt(id=1329502400960668056, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, companyId=1329502400922919318, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1 中国医学科学院 北京协和医学院 输血研究所,四川 成都 610052)])]), Author(id=1329502402235736510, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, orderNo=6, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=mary@ibt.pumc.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329502402298651072, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, authorId=1329502402235736510, language=EN, stringName=Li MA, firstName=Li, middleName=null, lastName=MA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1 Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu 610052, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329502402348982721, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, authorId=1329502402235736510, language=CN, stringName=马莉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1 中国医学科学院 北京协和医学院 输血研究所,四川 成都 610052, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329502400922919318, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, xref=1, ext=[AuthorCompanyExt(id=1329502400943890839, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, companyId=1329502400922919318, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1 Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu 610052, China), AuthorCompanyExt(id=1329502400960668056, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329449372530229324, companyId=1329502400922919318, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1 中国医学科学院 北京协和医学院 输血研究所,四川 成都 610052)])])]
潘旭,黄雨薇,毛烈火,孙盼,李长清,杜晞,马莉.
自制活化凝血酶原复合物的安全性和有效性评价[J].
中国输血杂志, 2026, 39(8): 1004-1011 DOI:10.13303/j.cjbt.issn.1004-549x.2026.08.002
| [1] |
SAHIN T K, ALADAG E, SETTERZADE E, et al. Spontaneous subepithelial hemorrhage of renal pelvis and ureter (Antopol-Goldman lesion) in hemophilia A patient with inhibitor: Case report and review of the literature[J].Medicine (Baltimore), 2020, 99(26):e20851.
|
| [2] |
MAHLANGU J, OLDENBURG J, PAZ-PRIEL I, et al. Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors[J].N Engl J Med, 2018, 379(9):811-822.
|
| [3] |
YOUNG G, LIESNER R, CHANG T, et al. A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors[J].Blood, 2019, 134(24):2127-2138.
|
| [4] |
PIPE S W, SHIMA M, LEHLE M, et al. Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HA-VEN 4): a multicentre, open-label, non-randomised phase 3 study[J].Lancet Haematol, 2019, 6 (6): e295-e305.
|
| [5] |
TEITEL J M. Treatment and prevention of bleeding in congenital hemophilia A patients with inhibitors[J].Transfus Apher Sci, 2018, 57(4):466-471.
|
| [6] |
KEMPTON C L, MEEKS S L. Toward optimal therapy for inhibitors in hemophilia[J]. Blood, 2014, 124 (23):3365-3372.
|
| [7] |
TELLIER Z, ANDRé M H, POLACK B. Management of haemophilia A-inhibitor patients:clinical and regulatory perspectives[J].Clin Rev Allergy Immunol, 2009, 37 (2):125-134.
|
| [8] |
HOFFMAN M, DARGAUD Y. Mechanisms and monitoring of bypassing agent therapy[J].J Thromb Haemost, 2012, 10(8):1478-1485.
|
| [9] |
KJALKE M, MADS KJELGAARD-HANSEN, ANDERS-EN S,et al. Thrombin generation potential in the pres-ence of concizumab and rFVIIa, APCC, rFⅧ, or rFIX: In vitro and ex vivo analyses[J].J Thromb Haemost, 2021, 19(7):1687-1696.
|
| [10] |
VARADI K, TANGADA S, LOESCHBERGER M, et al. Pro-and anticoagulant factors facilitate thrombin gen-eration and balance the haemostatic response to FEIBA® in prophylactic therapy[J].Haemophilia, 2016, 22 (4):615-624.
|
| [11] |
OLDENBURG J, MAHLANGU J N, KIM B, et al. Emi-cizumab Prophylaxis in Hemophilia A with Inhibitors[J].The New England journal of medicine, 2017, 377 (9):809-818.
|
| [12] |
HARTMANN R. In vitro studies show synergistic effects of a procoagulant bispecific antibody and bypassing agents[J].J Thromb Haemost, 2018,16(8):1580-1591.
|
| [13] |
KIZILOCAK H, ELIZABETH M C, WEE C P, et al. Comparison of bypassing agents in patients on emicizum-ab using global hemostasis assays[J].Haemophilia, 2021, 27(1):164-172.
|
| [14] |
KIZILOCAK H, ELIZABETH M C, MALVAR J, et al. Safety of FEIBA and emicizumab (SAFE):Dose escala-tion study evaluating the safety of in vivo administration of activated prothrombin complex concentrate in haemo-philia A patients on emicizumab[J]. Haemophilia, 2023, 29(1):100-105.
|
| [15] |
CROMWELL C, ALEDORT L M. FEIBA:a prohemosta-tic agent[J].Semin Thromb Hemost, 2012, 38 (3): 265-267.
|
| [16] |
EHRLICH H J, HENZL M J, GOMPERTS E D. Safety of factor Ⅷ inhibitor bypass activity (FEIBA):10-year compilation of thrombotic adverse events[J].Haemo-philia, 2002, 8(2):83-90.
|
| [17] |
GROTTKE, O, BRAUNSCHWEIG T, SPRONK H M, et al. Increasing concentrations of prothrombin complex concentrate induce disseminated intravascular coagulation in a pig model of coagulopathy with blunt liver injury[J].Blood, 2011, 118(7):1943-1951.
|
| [18] |
GHOSH, S,KREGE W, DOERR B, et al. Evaluation of the prothrombotic potential of four-factor prothrombin complex concentrate (4F-PCC) in animal models[J].PLoS One, 2021, 16(10):e0258192.
|
| [19] |
INGERSLEV J, SøRENSEN B. Parallel use of by-pass-ing agents in haemophilia with inhibitors:a critical review[J].Br J Haematol, 2011, 155(2):256-262.
|
| [20] |
BRIEN L. Anticoagulant Medications for the Prevention and Treatment of Thromboembolism[J].AACN Adv Crit Care, 2019, 30(2):126-138.
|
| [21] |
黄雨薇,赵娅菲,叶刚,等. 自制活化凝血酶原复合物 的主要药效成分分析[J].中国生物制品学杂志, 2025, 38(3):312-317.
|
| [22] |
HUANG Y W, ZHAO Y F, YE G, et al. Analysis of the primary active pharmaceutical ingredients in self-formula-ted activated prothrombin complex[J].Chinese Journal of Biological Products, 2025,38(3):312-317.
|
| [23] |
DINESS V, BREGENGAARD C, ERHARDTSEN E, et al. Recombinant human factor VIIa (rFVIIa) in a rabbit stasis model[J].Thromb Res, 1992, 67(2):233-241.
|
| [24] |
ELG M, CARLSSON S, GUSTAFSSON D. Effect of ac-tivated prothrombin complex concentrate or recombinant factor VIIa on the bleeding time and thrombus formation during anticoagulation with a direct thrombin inhibitor[J].Thromb Res, 2001, 101(3):145-157.
|
| [25] |
[24] MAJUMDER R. Not so fast, antithrombin![J]. Blood, 2023, 141(16):1907-1908.
|
基金资助
四川省科技计划项目,活化凝血酶原复合物制品的研究与开发(2021YFS0056)